Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021
Market Capitalization	177	193	491
Market Cap Growth	-	-60.71%	-
Enterprise Value	-24	-1	246
PE Ratio	-2.07	-3.81	-17.97
PB Ratio	0.79	0.93	1.99
P/FCF Ratio	-2.36	-5.77	-18.05
P/OCF Ratio	-2.36	-5.85	-18.05
EV/EBITDA Ratio	1.50	0.02	-9.01
EV/EBIT Ratio	1.49	0.02	-9.01
EV/FCF Ratio	1.69	0.04	-9.05
Debt / Equity Ratio	0.02	0.02	-
Debt / EBITDA Ratio	-0.07	-0.08	-
Debt / FCF Ratio	-0.07	-0.12	-
Quick Ratio	29.29	17.79	66.48
Current Ratio	29.93	18.16	67.38
Return on Equity (ROE)	-24.80%	-22.70%	-25.70%
Return on Assets (ROA)	-23.60%	-21.60%	-21.00%
Return on Capital (ROIC)	-29.15%	-25.56%	-11.09%
Earnings Yield	-31.98%	-26.25%	-5.56%
FCF Yield	-28.08%	-17.32%	-5.54%
Buyback Yield / Dilution	-13.52%	-299.61%	-1594.35%
Total Shareholder Return	-13.52%	-299.61%	-1594.35%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).